SOTHEMA (CAS:SOT) Research & Development: MAD7 Mil (TTM As of Dec. 2025)


CAS:SOT SOTHEMA CAS:SOT
75 GF Score
Price MAD376.00
GF Value MAD284.83
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is SOTHEMA Research & Development?

SOTHEMA CAS:SOT 75 Research & Development is MAD7 Mil as of Dec. 2025. GuruFocus rates CAS:SOT with a GF Score™ of 75/100 and a GF Value™ of MAD284.83 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. SOTHEMA's Research & Development for the six months ended in Dec. 2025 was MAD4 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was MAD7 Mil.

SOTHEMA  (CAS:SOT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

SOTHEMA Research & Development Related Terms

SOTHEMA Research & Development Historical Data

* Premium members only.

The historical data trend for SOTHEMA's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SOTHEMA Research & Development Chart

SOTHEMA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.09 7.78 5.39 6.70 7.42

SOTHEMA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.44 3.26 3.34 4.08
CAS:SOT
75GF Score
SOTHEMA CAS:SOT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SOTHEMA Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MAD7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of MAD7 Mil mean?
SOTHEMA (CAS:SOT) has a Research & Development of MAD7 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on SOTHEMA and its competitors.
Is SOTHEMA's Research & Development too high?
SOTHEMA's current Research & Development is MAD7 Mil. Overall, SOTHEMA has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SOTHEMA's Research & Development compare to LLY and JNJ?
SOTHEMA's Research & Development of MAD7 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on SOTHEMA and its competitors. SOTHEMA's current Research & Development is MAD7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SOTHEMA stock overvalued right now?
Based on GuruFocus' analysis, SOTHEMA (CAS:SOT) is currently considered Significantly Overvalued. The stock's GF Value™ is MAD284.83, compared to a current price of MAD376.00 — trading 32% above its estimated fair value. The current Research & Development is MAD7 Mil. SOTHEMA's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For SOTHEMA (CAS:SOT), the current Research & Development is MAD7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SOTHEMA (CAS:SOT) Overvalued in 2026?

Based on GuruFocus' analysis, SOTHEMA stock appears to be overvalued. The current stock price of MAD376.00 is trading 32% above its estimated GF Value™ of MAD284.83. GuruFocus considers SOTHEMA to be Significantly Overvalued.

Key valuation signals for CAS:SOT:

  • Research & Development: MAD7 Mil
  • GF Value™: MAD284.83 vs. price of MAD376.00 (32% above fair value)
  • GF Score™: 75/100 with 6 warning signs

No single metric tells the full story. See the CAS:SOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SOTHEMA Business Description

Address Centre de Bouskoura, BP no. 1, Casablanca, MAR
SOTHEMA engages in representation, purchase and sale of pharmaceutical, chemical, health-related, biological, veterinary, plant-based, cosmetic and scented products. The company sells its products in Morocco and overseas.
75GF Score

Get the complete analysis for CAS:SOT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MAD376.00
Price
MAD284.83
GF Value